Transactions
32
Insider / INTUITIVE SURGICAL INC
Charlton Henry L
EVP & Chief Commercial and Mkt at INTUITIVE SURGICAL INC
- Company
- INTUITIVE SURGICAL INC
- Ticker
- ISRG
- First filing on record
- November 13, 2025
- Latest trade on record
- February 28, 2026
- SEC filings
- EDGAR ↗
Charlton Henry L, EVP & Chief Commercial and Mkt at INTUITIVE SURGICAL INC, has disclosed 32 transactions in ISRG since November 13, 2025: 0 purchases (0 open-market buys) and 10 sales, worth about $13.5M at the reported prices. The latest was filed March 2, 2026, 2 days after the trade.
Open-market buys
0
Sales
10
Avg. disclosure lag
1.2d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Charlton Henry L made no purchases and 10 sales worth $11M, plus 22 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Charlton Henry L has traded 1 stock on record; the largest by dollars is ISRG.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 5 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 18 | 48,698 | $2.1M |
| F | Shares withheld for tax | 5 | 6,851 | $3.4M |
| S | Open-market sale | 5 | 13,731 | $8.0M |
| A | Grant or award | 4 | 17,666 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 19 | 0 | 5 · $3.4M |
| 2025 | 13 | 0 | 5 · $8.0M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| ISRG | Option / conversion M | February 28, 2026 | March 2, 2026 | 2d | 752 | — | — | derivative | Form 4 ↗ | |
| ISRG | Option / conversion M | February 28, 2026 | March 2, 2026 | 2d | 10,773 | — | — | derivative | Form 4 ↗ | |
| ISRG | Sell F | February 28, 2026 | March 2, 2026 | 2d | 4,800 | $504 | $2.4M | Form 4 ↗ | ||
| ISRG | Option / conversion M | February 28, 2026 | March 2, 2026 | 2d | 10,773 | — | — | Form 4 ↗ | ||
| ISRG | Sell F | February 28, 2026 | March 2, 2026 | 2d | 335 | $504 | $169K | Form 4 ↗ | ||
| ISRG | Option / conversion M | February 28, 2026 | March 2, 2026 | 2d | 752 | — | — | Form 4 ↗ | ||
| ISRG | Other A | February 26, 2026 | February 27, 2026 | 1d | 4,032 | — | — | derivative | Form 4 ↗ | |
| ISRG | Option / conversion M | February 26, 2026 | February 27, 2026 | 1d | 1,030 | — | — | derivative | Form 4 ↗ | |
| ISRG | Option / conversion M | February 26, 2026 | February 27, 2026 | 1d | 1,717 | — | — | derivative | Form 4 ↗ | |
| ISRG | Other A | February 26, 2026 | February 27, 2026 | 1d | 3,591 | — | — | derivative | Form 4 ↗ | |
| ISRG | Sell F | February 26, 2026 | February 27, 2026 | 1d | 459 | $506 | $232K | Form 4 ↗ | ||
| ISRG | Option / conversion M | February 26, 2026 | February 27, 2026 | 1d | 1,030 | — | — | Form 4 ↗ | ||
| ISRG | Sell F | February 26, 2026 | February 27, 2026 | 1d | 765 | $506 | $387K | Form 4 ↗ | ||
| ISRG | Option / conversion M | February 26, 2026 | February 27, 2026 | 1d | 1,717 | — | — | Form 4 ↗ | ||
| ISRG | Option / conversion M | February 10, 2026 | February 10, 2026 | 0d | 1,077 | — | — | derivative | Form 4 ↗ | |
| ISRG | Sell F | February 10, 2026 | February 10, 2026 | 0d | 492 | $493 | $242K | Form 4 ↗ | ||
| ISRG | Option / conversion M | February 10, 2026 | February 10, 2026 | 0d | 1,077 | — | — | Form 4 ↗ | ||
| ISRG | Other A | January 28, 2026 | January 30, 2026 | 2d | 7,182 | — | — | derivative | Form 4 ↗ | |
| ISRG | Other A | January 28, 2026 | January 30, 2026 | 2d | 2,861 | — | — | derivative | Form 4 ↗ | |
| ISRG | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 636 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| ISRG | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 2,565 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| ISRG | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 2,898 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| ISRG | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 2,901 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| ISRG | Sell S | November 12, 2025 | November 13, 2025 | 1d | 4,731 | $580 | $2.7M | 10b5-1 plan | Form 4 ↗ | |
| ISRG | Sell S | November 12, 2025 | November 13, 2025 | 1d | 2,901 | $580 | $1.7M | 10b5-1 plan | Form 4 ↗ | |
| ISRG | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 2,901 | $178 | $516K | 10b5-1 plan | Form 4 ↗ | |
| ISRG | Sell S | November 12, 2025 | November 13, 2025 | 1d | 2,898 | $580 | $1.7M | 10b5-1 plan | Form 4 ↗ | |
| ISRG | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 2,898 | $242 | $702K | 10b5-1 plan | Form 4 ↗ | |
| ISRG | Sell S | November 12, 2025 | November 13, 2025 | 1d | 2,565 | $580 | $1.5M | 10b5-1 plan | Form 4 ↗ | |
| ISRG | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 2,565 | $246 | $630K | 10b5-1 plan | Form 4 ↗ | |
| ISRG | Sell S | November 12, 2025 | November 13, 2025 | 1d | 636 | $580 | $369K | 10b5-1 plan | Form 4 ↗ | |
| ISRG | Option / conversion M | November 12, 2025 | November 13, 2025 | 1d | 636 | $347 | $221K | 10b5-1 plan | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| March 2, 2026 | Form 4 | 0001897642-26-000008 | 6 | published | EDGAR ↗ |
| February 27, 2026 | Form 4 | 0001897642-26-000006 | 8 | published | EDGAR ↗ |
| February 10, 2026 | Form 4 | 0001897642-26-000004 | 3 | published | EDGAR ↗ |
| January 30, 2026 | Form 4 | 0001897642-26-000002 | 2 | published | EDGAR ↗ |
| November 13, 2025 | Form 4 | 0001897642-25-000004 | 13 | published | EDGAR ↗ |
Other insiders at INTUITIVE SURGICAL INC
- Curet Myriam EVP & Chief Medical Officer 59 rows
- Brosius Mark EVP & Chief Mfg and Supply Cha 53 rows
- Rosa David J. Chief Executive Officer (CEO) 34 rows
- GUTHART GARY S Director 33 rows
- Widman Fredrik VP Corporate Controller 28 rows
- LOEB GARY EVP & Chief Legal and Complian 25 rows
- Jeddi Iman SVP & GM da Vinci Platforms & 20 rows
- Samath Jamie Director 20 rows
- BARRATT CRAIG H Director 15 rows
- CHEW LEWIS Director 13 rows
Everyone on file, with contracts and lobbying under the company's name: INTUITIVE SURGICAL INC.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 5 | 32 | November 13, 2025 | March 2, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.